The Boston-based pharmaceutical company said the Phase 2 trial showed that setmelanotide was effective in reducing body mass index and hyperphagia in patients with Prader-Willi syndrome, a genetic ...

Rhythm Pharmaceuticals said Thursday said it would send it would send its leading drug into registrational testing for Prader ...

Rhythm Pharma rises after early Prader-Willi trial data show reduced hunger and BMI, supporting plans for a Phase 3 study of setmelanotide.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

Rhythm Pharma (RYTM) added ~15% on Thursday after the company announced plans to advance its lead asset, setmelanotide, into ...

BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month ...

Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readoutClinical trial sites in Canada and the ...

When 15-year-old Anna Hankins accepted the title of Miss Amazing in Chicago, the Mississippi teen was beaming not only because of the award, but also because of the opportunity to raise awareness ...

Prader-Willi Syndrome affects thousands of children in the United States, yet is relatively unknown to the general population. This genetic condition, resulting from an abnormality on the 15th ...

Haley Kavrell, 17, who must cope with Prader-Willi syndrome, which causes her to feel constant hunger, picks basil at her home in Davis late last month. Renée C. Byer [email protected] After receiving ...

MINNEAPOLIS (WCCO) --No parent wants their child to suffer from hunger pains, but for one Twin Cities family, that's a constant struggle. Two-year-old Nick Joncas never feels full. He has a disease ...

Stem cell researchers have reversed Prader-Willi syndrome in brain cells growing in the lab. The discovery provides clues that could lead to a treatment for Prader-Willi, a genetic disorder that ...